XBI

Is Now the Time to Buy Into These 5 Biotech ETFs?

By
After a painful 2016, biotech stocks are recovering this year. What lies ahead? Let's look at 5 biotech ETFs to find out

3 Ways to Play This Biotech Stocks Dip

By Tyler Craig, Tales of a Technician
Biotech stocks have retraced to an attractive buy point. Consider these three plays on XBI, CELG and AMGN.

Buy Today’s Trump Dump in Biotech Stocks – XBI IBB

By Kyle Woodley, Senior Investing Editor, Kiplinger
Biotech stocks and ETFs like iShares' IBB and SPDR's XBI were hammered Wednesday on Donald Trump's drug pricing comments. Opportunity knocks.

SPDR S&P Biotech (ETF) (XBI): Get on Board the Biotech Train!

By Tim Biggam, InvestorPlace Contributor
Biotech stocks have gained the wind, but the SPDR S&P Biotech (ETF) (XBI) hasn't yet caught up with the market. That's going to change soon.

5 Stocks to Buy Ahead of the “January Effect”

By Vince Martin, InvestorPlace Contributor
Small caps with "tax loss selling" in December often make great buys in January. Here's a list of five potential opportunities for 2017.

Surf the Biotech Channel with the SPDR S&P Biotech (ETF) (XBI)

By Tyler Craig, Tales of a Technician
The biotech stock pop is fading, but opportunity lurks for bulls and bears, and you can use the XBI ETF to make some money on its next move.

Try the SPDR S&P Biotech (ETF) (XBI) if You’re Bullish on the Biotech Pause

By Tyler Craig, Tales of a Technician
Biotech stocks remain under accumulation post-election. Play XBI on the cheap to profit from the expected continued upside.

Buy the SPDR S&P Biotech (ETF) (XBI) TODAY – Here’s Why

By Kyle Woodley, Senior Investing Editor, Kiplinger
Biotech stocks and the SPDR S&P Biotech ETF (XBI) just shook off a major bugaboo in Hillary Clinton. The XBI ETF will soar as a result.

Three Big Stock Charts: Metlife Inc (MET), Apple Inc. (AAPL) and SPDR S&P Biotech ETF (XBI)

By Johnson Research Group
Apple (AAPL) and the SPDR S&P Biotech ETF (XBI) are going to see selling pressure while Metlife (MET) is unlikely to see the same decline.

Dump Horizon Pharma PLC (HZNP) Stock Now! Don’t Wait!

By Jeff Reeves
Horizon Pharma is fading after ugly guidance, and the HZNP stock chart is terrible. Sell this biotech stock before its November report.

Go Long Biotech Stocks for a Donald Trump Win (LABU)

By Nicolas Chahine, InvestorPlace Contributor
Recently Trump has been gaining in the polls. A Trump win could cause a rally in the biotech sector. Buy calls into the elections.

SPDR S&P Biotech (ETF) (XBI): The Bears Got Nothin’ on Biotech Stocks

By Tyler Craig, Tales of a Technician
Buyers are dominating in biotech stocks. Embrace the relative strength with this XBI play. High-probability profits await.

Biotech SPDR (XBI): Opportunity Lurks Amid the Biotech Swoon

By Tyler Craig, Tales of a Technician
The biotech stock swoon is a blip on the radar, nothing more. Fade the fear by selling juiced up XBI put options.

The 10 Best ETFs on the Planet

By Kyle Woodley, Senior Investing Editor, Kiplinger
The best ETFs on the planet will outperform because of powerful generational megatrends, or just because they're built to withstand anything.

SPDR S&P Biotech (ETF) (XBI): Embrace the Biotech Bulls’ Return

By Tyler Craig, Tales of a Technician
Strength is returning anew to biotech stocks. Embrace the sector with a play on XBI to capitalize on further gains.

Gilead Sciences, Inc.: A Breakdown Looms for GILD Stock

By Tyler Craig, Tales of a Technician
Gilead Sciences is sitting out the biotech stock rally. In fact, an ugly breakdown looms for the ailing drug stock. Buy GILD stock puts.

3 High-Growth ETFs That Are Just Waiting to Explode

By Kyle Woodley, Senior Investing Editor, Kiplinger
Investors have lost their nerve for now, but these growth plays are going to be prime buying grounds the second Wall Street perks up.

Biotech Bloodbath: Ditch XBI, IBB for Now

By Kyle Woodley, Senior Investing Editor, Kiplinger
Biotech ETFs IBB and XBI are in a hurt locker right now. Even if you're bullish on biotechs for the long-term, consider a hedge play or two for now.

10 Stocks to Buy for a Set-It-and-Forget-It Summer Portfolio

By James Brumley, InvestorPlace Feature Writer
If you actually want to do other things besides sit in front of a computer for the next few months, here's a closer look at the best stocks to buy and hold into August.
Load More